Page last updated: 2024-11-07

methylprednisolone acetate and Congestive Ophthalmopathy

methylprednisolone acetate has been researched along with Congestive Ophthalmopathy in 2 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sisti, E2
Coco, B2
Menconi, F2
Leo, M2
Rocchi, R2
Latrofa, F2
Profilo, MA2
Mazzi, B2
Albano, E1
Vitti, P2
Marcocci, C2
Brunetto, M2
MarinĂ², M2

Other Studies

2 other studies available for methylprednisolone acetate and Congestive Ophthalmopathy

ArticleYear
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
    European journal of endocrinology, 2015, Volume: 172, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Chemi

2015
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
    Thyroid : official journal of the American Thyroid Association, 2015, Volume: 25, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotra

2015